Dr Nathalie Doorenweerd Professor Annemieke Aartsma-Rus
| Longitudinal follow-up of verbal span and processing speed in Duchenne muscular dystrophy | 2020 |
|
Dr John Bourke Professor Michela Guglieri Professor Annemieke Aartsma-Rus Dr Guy MacGowan
| 238th ENMC International Workshop: Updating management recommendations of cardiac dystrophinopathyHoofddorp, The Netherlands, 30 November - 2 December 2018 | 2019 |
|
Dr Nathalie Doorenweerd Professor Annemieke Aartsma-Rus
| Erratum: Author Correction: Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy (Scientific reports (2017) 7 1 (12575)) | 2018 |
|
Professor Hanns Lochmuller Dr Dorota Badowska Rachel Thompson Professor Annemieke Aartsma-Rus Libby Wood et al. | RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases | 2018 |
|
Dr Mojgan Reza Professor Vishna Devi V Nadarajah Professor Hanns Lochmuller Professor Annemieke Aartsma-Rus
| Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne | 2017 |
|
Dr Ingrid Verhaart Agata Robertson Dr Ian Wilson Professor Annemieke Aartsma-Rus Dr Shona Cameron et al. | Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - A literature review | 2017 |
|
Becca Leary Dr Anne Oyewole Emerita Professor Katherine Bushby Professor Annemieke Aartsma-Rus
| Translational Research in Europe for theAssessment and Treatment for NeuromuscularDisorders (TREAT-NMD) | 2017 |
|
Professor Annemieke Aartsma-Rus Professor Volker Straub Professor Hanns Lochmuller
| Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy | 2016 |
|
Dr Mattia Calissano Professor Hanns Lochmuller Professor Annemieke Aartsma-Rus
| Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients | 2016 |
|
Professor Volker Straub Emerita Professor Katherine Bushby Dr Monica Ensini Professor Annemieke Aartsma-Rus
| Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy | 2016 |
|
Dr Stephen Lynn Professor Annemieke Aartsma-Rus Emerita Professor Katherine Bushby Dr Anna Mayhew Professor Volker Straub et al. | Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy | 2015 |
|
Dr Catherine Bladen Professor Jordi Diaz Manera Professor Volker Straub Emerita Professor Katherine Bushby Professor Annemieke Aartsma-Rus et al. | The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations | 2015 |
|
Dr Amina Chaouch Emerita Professor Katherine Bushby Professor Volker Straub Professor Hanns Lochmuller Professor Annemieke Aartsma-Rus et al. | Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants | 2015 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy | 2014 |
|
Dr Mojgan Reza Professor Vishna Devi V Nadarajah Dr Mattia Calissano Professor Hanns Lochmuller Professor Annemieke Aartsma-Rus et al. | MMP-9 serum levels increase over time in Duchenne muscular dystrophy patients and decrease upon treatment with drisapersen | 2014 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| The dynamics of compound, transcript, and protein effects after treatment With 2OMePS antisense oligonucleotides in mdx mice | 2014 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| DMD transcript imbalance determines dystrophin levels | 2013 |
|
Morten Ritso Dr Steven Laval Dr Rita Barresi Professor Annemieke Aartsma-Rus Professor Hanns Lochmuller et al. | Exon Skipping and Gene Transfer Restore Dystrophin Expression in Human Induced Pluripotent Stem Cells-Cardiomyocytes Harboring DMD Mutations | 2013 |
|
Morten Ritso Dr Steven Laval Dr Rita Barresi Professor Annemieke Aartsma-Rus Professor Hanns Lochmuller et al. | Gene therapy to restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutations | 2013 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| AON-Mediated Exon Skipping for Duchenne Muscular Dystrophy | 2012 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging | 2012 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| Gene therapy for Duchenne muscular dystrophy | 2012 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy | 2012 |
|
Dr Ingrid Verhaart Professor Annemieke Aartsma-Rus
| The effect of 6-thioguanine on alternative splicing and antisense-mediated exon skipping treatment for duchenne muscular dystrophy | 2012 |
|